Glycocheno<wbr/>deoxycholic Acid (sodium salt hydrate)

Glycochenodeoxycholic Acid (sodium salt hydrate)

CAT N°: 16942
Price:

From 48.00 40.80

Glycochenodeoxycholic acid (GCDCA) is a glycine-conjugated form of the primary bile acid chenodeoxycholic acid (Item No. 10011286).{57144} It reduces formation of cholic acid (Item No. 20250) in primary human hepatocytes when used at a concentration of 100 µM.{57145} GCDCA (50, 75, and 100 µM) reduces the number of LC3 puncta, a marker of autophagy, and is cytotoxic to L-02 hepatocytes.{57144} GCDCA (50 µM) induces apoptosis in isolated rat hepatocytes, an effect that can be blocked by the protein kinase C (PKC) inhibitor chelerythrine (Item No. 11314).{57146} Fecal levels of GCDCA are decreased in a rat model of high-fat diet-induced obesity compared with rats fed a normal diet.{54007}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • N-[(3?,5?,7?)-3,7-dihydroxy-24-oxocholan-24-yl]-glycine, monosodium salt, hydrate
  • Correlated keywords
    • 16564-43-5 640-79-9 NSC681056 DSHS 00533 LC 3 L02 chenodeoxycholylglycine glycochenodeoxycholate glycochenodesoxycholate glycylchenodeoxycholate
  • Product Overview:
    Glycochenodeoxycholic acid (GCDCA) is a glycine-conjugated form of the primary bile acid chenodeoxycholic acid (Item No. 10011286).{57144} It reduces formation of cholic acid (Item No. 20250) in primary human hepatocytes when used at a concentration of 100 µM.{57145} GCDCA (50, 75, and 100 µM) reduces the number of LC3 puncta, a marker of autophagy, and is cytotoxic to L-02 hepatocytes.{57144} GCDCA (50 µM) induces apoptosis in isolated rat hepatocytes, an effect that can be blocked by the protein kinase C (PKC) inhibitor chelerythrine (Item No. 11314).{57146} Fecal levels of GCDCA are decreased in a rat model of high-fat diet-induced obesity compared with rats fed a normal diet.{54007}

We also advise you